Piperacillin-tazobactam versus cefepime monotherapy in pediatric patients with febrile neutropenia: a systematic review and meta-analysis
European Journal of Pediatrics · 07.05.2026 · 185 (6)
DOI: 10.1007/s00431-026-07003-4 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Journal of Pediatrics, online erschienen am 07.05.2026. Verfasst von Bernardo Luís Giacomelli Fernandes und 2 weiteren Autor:innen. Beteiligte Einrichtung: Universidade de Brasília (UnB), Brasília, Brazil. bernardolgf1@gmail.com. Hauptthemen laut MEDLINE: Cefepime, Anti-Bacterial Agents, Febrile Neutropenia, Piperacillin, Tazobactam Drug Combination. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
The purpose of this study is to evaluate whether piperacillin-tazobactam therapy, compared with cefepime monotherapy, results in significant difference in treatment success, mortality, and duration outcomes in pediatric patients with febrile neutropenia (FN). A systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted following PRISMA guidelines. PubMed, Embase, Scopus, Web of Science, and Cochrane CENTRAL were searched up to February 3. No starting limits for dates were used. We only included studies of pediatric patients with FN comparing piperacillin-tazobactam to cefepime monotherapy. Risk of bias was assessed using Cochrane RoB 2 tool. Meta-analysis was performed using random-effects model to calculate risk ratios (RR) and mean differences (MD). Five RCTs involving 470 episodes were included. The pooled analysis for treatment success showed no statistically significant difference between groups (RR = 1.02; 95% CI [0.89; 1.18]; P = 0.76) with low heterogeneity (I2 = 0.0%). No significant differences for mortality (RR = 2.09; 95% CI [0.62; 7.03]; P = 0.23; I2 = 0.0%). Duration of treatment was 0.9 day shorter for cefepime group (MD = 0.9 day; 95% CI [0.2; 1.6]; P < 0.1; I2 = 0%). Conclusion: No statistically significant difference was found in treatment success or mortality between the groups. Patients receiving cefepime had a treatment duration 0.9 days shorter than those receiving piperacillin-tazobactam, although this finding should be interpreted with caution. The available evidence remains limited. Further RCTs are needed to elucidate potential differences in treatment success, mortality, and duration between the drugs. Registration: PROSPERO (CRD420261296621). What is Known: • Cefepime and piperacillin-tazobactam are widely utilized as empirical monotherapy for febrile neutropenia, but evidence regarding their comparative clinical efficacy and safety in children remains inconclusive. What is New: • This meta-analysis quantifies differences in treatment success, mortality and duration of treatment outcomes in pediatric patients with febrile neutropenia. What is Known: • Cefepime and piperacillin-tazobactam are widely utilized as empirical monotherapy for febrile neutropenia, but evidence regarding their comparative clinical efficacy and safety in children remains inconclusive. What is New: • This meta-analysis quantifies differences in treatment success, mortality and duration of treatment outcomes in pediatric patients with febrile neutropenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Universidade de Brasília (UnB), Brasília, Brazil. bernardolgf1@gmail.com.
- University of Western Australia, Perth, Australia.
- Universidade de Brasília (UnB), Brasília, Brazil.
Zitieren
APA
Fernandes, B. L. G., Joseph, A., & Andriazzi, V. H. (2026). Piperacillin-tazobactam versus cefepime monotherapy in pediatric patients with febrile neutropenia: a systematic review and meta-analysis. European Journal of Pediatrics, 185(6). https://doi.org/10.1007/s00431-026-07003-4
Vancouver
Fernandes BLG, Joseph A, Andriazzi VH. Piperacillin-tazobactam versus cefepime monotherapy in pediatric patients with febrile neutropenia: a systematic review and meta-analysis. European Journal of Pediatrics. 2026;185(6). doi:10.1007/s00431-026-07003-4
BibTeX
@article{Fernandes2026,
author = {Fernandes, Bernardo Luís Giacomelli and Joseph, Allan and Andriazzi, Vítor Honorato},
title = {Piperacillin-tazobactam versus cefepime monotherapy in pediatric patients with febrile neutropenia: a systematic review and meta-analysis},
journal = {European Journal of Pediatrics},
year = {2026},
volume = {185},
number = {6},
doi = {10.1007/s00431-026-07003-4}
}
EUVIMED